Company Filing History:
1 out of 4 
1 out of 636 
1 out of 114 
Years Active: 2021-2024
Title: Innovations by Kerri Ford: Pioneering Research in Inflammatory Diseases
Introduction
Kerri Ford, an accomplished inventor based in South San Francisco, California, is making strides in the field of biomedical research. With two patents to her name, her work focuses on biomarkers and methods that assess the risk of serious health conditions in patients battling inflammatory diseases, particularly rheumatoid arthritis.
Latest Patents
Kerri Ford's latest patents delve into the critical intersection of inflammatory diseases and cardiovascular health. One notable patent outlines methods for assessing the risk of infection or cardiovascular disease (CVD) in individuals suffering from rheumatoid arthritis. The patented methods utilize immunoassays to generate scores based on quantitative data concerning the expression of inflammatory biomarkers. These scores, when combined with additional clinical variables, allow healthcare providers to evaluate infection and CVD risk effectively. Furthermore, the patents emphasize the importance of inflammatory biomarkers in informing treatment decisions for patients.
Career Highlights
Throughout her career, Kerri Ford has contributed significantly to the research community. She has held positions at esteemed organizations such as Crescendo Bioscience, which focuses on precision medicine, and The UAB Research Foundation, known for its commitment to advancing scientific research. Her impactful work enhances the understanding of how inflammatory diseases can affect overall health and guides better treatment pathways.
Collaborations
Collaboration plays a vital role in Kerri Ford's work. She has had the opportunity to work alongside renowned colleagues, including Jeffrey R. Curtis. These partnerships enrich her research and expand the potential impact of her innovations on the medical community.
Conclusion
Kerri Ford's contributions to biotechnology through her patented innovations are paving the way for improved healthcare outcomes for patients with inflammatory diseases. Her ongoing research and collaborations promise to enhance the understanding of disease mechanisms and inform more effective treatment strategies, making her a notable figure in her field.